Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Biomaterials. 2008 Dec 25;30(8):1542–1550. doi: 10.1016/j.biomaterials.2008.11.011

Table I.

TEBV mechanical properties and source patient characteristics

Patient demographics and individual mechanical properties of TEBVs

Patient Demographics
Comorbidities
Graft Indication Mechanical Properties
ID Gender Age Sm Diab CH PGI PGF Internal Diameter (mm) Burst Pressure (mmHg) Suture Retention (grams-force) Compliance (%/100mmHg)
1 F 56 x x x AV 4.8 3,123 +/− 340 (n=12) (range: 2,596–3,759) 188 +/− 36 (n=36) (range: 103–250) 2.8 +/− 1.5 (n=5) (range: 0.9–4.0)
2 M 61 CS x x x x AV 4.8 2,664 +/− 347 (n=10) (range: 2,102–3,386) 142 +/− 16 (n=30) (range: 113–173) 4.7 +/− 1.0 (n=5) (range: 3.6–5.5)
3 F 68 x x x AV 4.8 4,617 +/− 426 (n=12) (range: 3,969–5,193) 210 +/− 27 (n=36) (range: 163–268) 2.8 +/− 0.7 (n=6) (range: 2.0–3.5)
4 M 77 x x x AV 4.8 3,019 +/− 594 (n=12) (range: 1,675–3,708) 149 +/− 21 (n=36) (range: 87–186) 2.9 +/− 1.9 (n=6) (range: 1.4–6.0)
5 M 29 x x x AV 4.8 3,657 +/− 268 (n=12) (range: 3,143–4,040) 162 +/− 23 (n=36) (range: 103–203) 2.5 +/− 1.9 (n=6) (range: 0.3–5.3)
6 M 78 PS x x x AV 4.8 2,348 +/− 221 (n=12) (range: 2,000–2,840) 75 +/− 10 (n=36) (range: 56–103) 4.1 +/− 3.7 (n=6) (range: 0.9–9.3)
7 M 89 x x x AV 4.8 4,140 +/− 690 (n=10) (range: 3,171–4,945) 221 +/− 14 (n=30) (range: 191–256) 3.8 +/− 1.0 (n=5) (range: 2.7–5.2)
8 F 62 CS x x x AV 4.8 2,582 +/− 330 (n=6) (range: 2,111–2,915) 98 +/− 13 (n=15) (range: 77–128) 2.1 +/− 1.8 (n=3) (range: 0.8–4.1)
9 F 58 x x AV 4.8 4,424 +/− 898 (n=10) (range: 2,255–5,159) 199 +/− 23 (n=30) (range: 149–266) 2.6 +/− 1.2 (n=6) (range: 1.1–4.5)
10 F 54 CS x x x x AV 4.8 4,542 +/− 453 (n=10) (range: 3,719–5,315) 112 +/− 12 (n=30) (range: 87–146) 3.5 +/− 0.7 (n=5) (range: 2.4–4.1)
11 M 71 x x x x AV 4.8 2,412 +/− 319 (n=10) (range: 1,855–2,959) 180 +/− 21 (n=30) (range: 132–218) 3.4 +/− 0.7 (n=5) (range: 2.8–4.4)
12 F 67 x x AV 4.8 4,994 +/− 594 (n=6) (range: 4,170–5,763) 212 +/− 19 (n=18) (range: 188–250) 3.1 +/− 0.3 (n=3) (range: 2.9–3.4)
13 F 81 x x x x AV 4.8 3,426 +/− 271 (n=8) (range: 2,922–3,726) 165 +/− 22 (n=24) (range: 110–221) 4.6 +/− 0.2 (n=4) (range: 2.9–3.4)
14 M 26 CS x x x AV 4.8 4,341 +/− 506 (n=8) (range: 3,698–4,957) 187 +/− 20 (n=24) (range: 158–227) 3.6 +/− 1.4 (n=4) (range: 2.7–5.7)
15 F 59 x x x AV 4.8 2,803 +/− 208 (n=4) (range: 2,600–3,045) 141 +/− 12 (n=12) (range: 122–163) 6.1 +/− 0.1 (n=2) (range: 6.0–6.1)
16 F 76 PS LL 6.6 3,358 +/− 499 (n=5) (range: 2,870–4,122) 291 +/− 55 (n=15) (range: 159–359) 2.5 +/− 2.6 (n=3) (range: 0.4–5.3)
17 M 62 PS x LL 6.6 3,035 +/− 315 (n=5) (range: 2,691–3,454) 157 +/− 18 (n=12) (range: 130–184) 2.1 +/− 1.1 (n=3) (range: 0.9–3.0)
18 M 75 PS x x x LL 6.6 3,101 +/− 364 (n=8) (range: 2,683–3,770) 131 +/− 12 (n=24) (range: 108–152) 3.8 +/− 2.0 (n=5) (range: 1.6–6.2)
19 M 47 PS x x x AV 4.8 4,549 +/− 380 (n=4) (range: 4,120–5,032) 184 +/− 20 (n=12) (range: 154–220) 4.5 +/− 0.2 (n=2) (range: 4.4–4.7)
20 M 77 PS x x x LL 6.6 3,693 +/− 457 (n=9) (range: 2,726–4,238) 119 +/− 15 (n=24) (range: 82–142) 4.1 +/− 0.4 (n=3) (range: 3.7–4.5)
21 M 73 x x x LL 6.6 3,650 +/− 338 (n=7) (range: 3,124–3,988) 171 +/− 12 (n=18) (range: 132–187) 2.3 +/− 0.3 (n=3) (range: 2.0–2.7)
22 M 67 x x x x RAD 2.4 2,285 +/− 220 (n=8) (range: 2,001–2,617) 95 +/− 24 (n=24) (range: 61–155) not performed
23 F 59 x RAD 2.4 3,467 +/− 422 (n=10) (range: 2,835–4,163) 138 +/− 27 (n=12) (range: 96–182) 4.1 +/− 0.4 (n=3) (range: 3.0–5.3)
24 F 45 x AV 4.8 3,970 +/− 515 (n=20) (range: 2,842–4,817) 104 +/− 14 (n=60) (range: 70–148) 3.0 +/− 1.5 (n=10) (range: 0.7–5.8)
25 M 57 PS RAD 2.4 4,832 +/− 897 (n=8) (range: 3,880 + 6,269) 123 +/− 23 (n=24) (range: 57–170) 3.2 +/− 1.2 (n=4) (range: 2.1–4.3)

Sm: Smoker PS: Previous smoker CS: Current smoker Diab: Diabetes CH: Controlled hypertension PGI: Previous graft intervention PGF: Prev. graft failure LL: Lower limb AV: A-V shunt RAD: Radial artery replacement